img

Global Allergy Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Allergy Vaccine Market Insights, Forecast to 2034

Allergen Vaccine, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
Global Allergy Vaccine market is expected to reach to US$ 1697 million in 2024, with a positive growth of %, compared with US$ 1586 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Allergy Vaccine industry is evaluated to reach US$ 2546.7 million in 2029. The CAGR will be 7.0% during 2024 to 2029.
The market driver for Desensitization Treatment is the increasing prevalence of allergies and the growing need for effective allergy management. Desensitization treatment, also known as immunotherapy, offers a potential cure for allergies by reducing sensitivity to allergens. Rising awareness of the treatment's benefits and advancements in allergy research contribute to market growth. However, challenges include the lengthy treatment duration, potential side effects, and the need for personalized treatment plans. Additionally, reimbursement issues and the availability of alternative allergy management options may pose challenges for market adoption. Despite challenges, the Desensitization Treatment market presents opportunities for improved patient outcomes and better quality of life for individuals with allergies, driving further research and innovation in allergy care.
Report Covers
This report presents an overview of global Allergy Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Allergy Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
WOLW Pharma
HAL
Holister Stier
Leti
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy

Segment by Application


Allergic Rhinitis
Allergic Asthma
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Allergy Vaccine plant distribution, commercial date of Allergy Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Allergy Vaccine introduction, etc. Allergy Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Allergy Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Allergy Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Allergy Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Allergy Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Allergy Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Allergy Vaccine Revenue by Region
2.2.1 Global Allergy Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Allergy Vaccine Revenue by Region (2018-2024)
2.2.3 Global Allergy Vaccine Revenue by Region (2024-2029)
2.2.4 Global Allergy Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Allergy Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Allergy Vaccine Sales by Region
2.4.1 Global Allergy Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Allergy Vaccine Sales by Region (2018-2024)
2.4.3 Global Allergy Vaccine Sales by Region (2024-2029)
2.4.4 Global Allergy Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Allergy Vaccine Sales by Manufacturers
3.1.1 Global Allergy Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Allergy Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Allergy Vaccine in 2022
3.2 Global Allergy Vaccine Revenue by Manufacturers
3.2.1 Global Allergy Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Allergy Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Allergy Vaccine Revenue in 2022
3.3 Global Key Players of Allergy Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Allergy Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Allergy Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Allergy Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Allergy Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Allergy Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Allergy Vaccine Sales by Type
4.1.1 Global Allergy Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Allergy Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Allergy Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Allergy Vaccine Revenue by Type
4.2.1 Global Allergy Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Allergy Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Allergy Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Allergy Vaccine Price by Type
4.3.1 Global Allergy Vaccine Price by Type (2018-2024)
4.3.2 Global Allergy Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Allergy Vaccine Sales by Application
5.1.1 Global Allergy Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Allergy Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Allergy Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Allergy Vaccine Revenue by Application
5.2.1 Global Allergy Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Allergy Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Allergy Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Allergy Vaccine Price by Application
5.3.1 Global Allergy Vaccine Price by Application (2018-2024)
5.3.2 Global Allergy Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Allergy Vaccine Market Size by Type
6.1.1 US & Canada Allergy Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Allergy Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Allergy Vaccine Market Size by Application
6.2.1 US & Canada Allergy Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Allergy Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Allergy Vaccine Market Size by Country
6.3.1 US & Canada Allergy Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Allergy Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Allergy Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Allergy Vaccine Market Size by Type
7.1.1 Europe Allergy Vaccine Sales by Type (2018-2029)
7.1.2 Europe Allergy Vaccine Revenue by Type (2018-2029)
7.2 Europe Allergy Vaccine Market Size by Application
7.2.1 Europe Allergy Vaccine Sales by Application (2018-2029)
7.2.2 Europe Allergy Vaccine Revenue by Application (2018-2029)
7.3 Europe Allergy Vaccine Market Size by Country
7.3.1 Europe Allergy Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Allergy Vaccine Sales by Country (2018-2029)
7.3.3 Europe Allergy Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Allergy Vaccine Market Size
8.1.1 China Allergy Vaccine Sales (2018-2029)
8.1.2 China Allergy Vaccine Revenue (2018-2029)
8.2 China Allergy Vaccine Market Size by Application
8.2.1 China Allergy Vaccine Sales by Application (2018-2029)
8.2.2 China Allergy Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Allergy Vaccine Market Size by Type
9.1.1 Asia Allergy Vaccine Sales by Type (2018-2029)
9.1.2 Asia Allergy Vaccine Revenue by Type (2018-2029)
9.2 Asia Allergy Vaccine Market Size by Application
9.2.1 Asia Allergy Vaccine Sales by Application (2018-2029)
9.2.2 Asia Allergy Vaccine Revenue by Application (2018-2029)
9.3 Asia Allergy Vaccine Sales by Region
9.3.1 Asia Allergy Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Allergy Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Allergy Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Allergy Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Allergy Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Allergy Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Allergy Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Allergy Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Allergy Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Allergy Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Allergy Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Allergy Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Allergy Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ALK-Abello
11.1.1 ALK-Abello Company Information
11.1.2 ALK-Abello Overview
11.1.3 ALK-Abello Allergy Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 ALK-Abello Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ALK-Abello Recent Developments
11.2 Stallergenes Greer
11.2.1 Stallergenes Greer Company Information
11.2.2 Stallergenes Greer Overview
11.2.3 Stallergenes Greer Allergy Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Stallergenes Greer Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Stallergenes Greer Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Allergy Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Merck Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Allergy Therapeutics
11.4.1 Allergy Therapeutics Company Information
11.4.2 Allergy Therapeutics Overview
11.4.3 Allergy Therapeutics Allergy Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Allergy Therapeutics Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Allergy Therapeutics Recent Developments
11.5 WOLW Pharma
11.5.1 WOLW Pharma Company Information
11.5.2 WOLW Pharma Overview
11.5.3 WOLW Pharma Allergy Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 WOLW Pharma Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 WOLW Pharma Recent Developments
11.6 HAL
11.6.1 HAL Company Information
11.6.2 HAL Overview
11.6.3 HAL Allergy Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 HAL Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 HAL Recent Developments
11.7 Holister Stier
11.7.1 Holister Stier Company Information
11.7.2 Holister Stier Overview
11.7.3 Holister Stier Allergy Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Holister Stier Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Holister Stier Recent Developments
11.8 Leti
11.8.1 Leti Company Information
11.8.2 Leti Overview
11.8.3 Leti Allergy Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Leti Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Leti Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Allergy Vaccine Industry Chain Analysis
12.2 Allergy Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Allergy Vaccine Production Mode & Process
12.4 Allergy Vaccine Sales and Marketing
12.4.1 Allergy Vaccine Sales Channels
12.4.2 Allergy Vaccine Distributors
12.5 Allergy Vaccine Customers
13 Market Dynamics
13.1 Allergy Vaccine Industry Trends
13.2 Allergy Vaccine Market Drivers
13.3 Allergy Vaccine Market Challenges
13.4 Allergy Vaccine Market Restraints
14 Key Findings in The Global Allergy Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Allergy Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Subcutaneous Immunotherapy
Table 3. Major Manufacturers of Sublingual Immunotherapy
Table 4. Global Allergy Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Allergy Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Allergy Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Allergy Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Allergy Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Allergy Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Allergy Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Allergy Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Allergy Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Allergy Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Allergy Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Allergy Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Allergy Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Allergy Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Allergy Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Allergy Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Allergy Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Allergy Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Allergy Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Vaccine as of 2022)
Table 23. Global Key Manufacturers of Allergy Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Allergy Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Allergy Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Allergy Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Allergy Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Allergy Vaccine Sales Share by Type (2018-2024)
Table 30. Global Allergy Vaccine Sales Share by Type (2024-2029)
Table 31. Global Allergy Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Allergy Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Allergy Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Allergy Vaccine Revenue Share by Type (2024-2029)
Table 35. Allergy Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Allergy Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Allergy Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Allergy Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Allergy Vaccine Sales Share by Application (2018-2024)
Table 40. Global Allergy Vaccine Sales Share by Application (2024-2029)
Table 41. Global Allergy Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Allergy Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Allergy Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Allergy Vaccine Revenue Share by Application (2024-2029)
Table 45. Allergy Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Allergy Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Allergy Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Allergy Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Allergy Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Allergy Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Allergy Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Allergy Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Allergy Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Allergy Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Allergy Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Allergy Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Allergy Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Allergy Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Allergy Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Allergy Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Allergy Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Allergy Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Allergy Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Allergy Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Allergy Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Allergy Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Allergy Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Allergy Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Allergy Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Allergy Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Allergy Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Allergy Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Allergy Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Allergy Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Allergy Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Allergy Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Allergy Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Allergy Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Allergy Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Allergy Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Allergy Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Allergy Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Allergy Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Allergy Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Allergy Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Allergy Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Allergy Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Allergy Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Allergy Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Allergy Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Allergy Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Allergy Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Allergy Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Allergy Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Allergy Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Allergy Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Allergy Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Allergy Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Allergy Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Allergy Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Allergy Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Allergy Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Allergy Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Allergy Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Allergy Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Allergy Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. ALK-Abello Company Information
Table 108. ALK-Abello Description and Major Businesses
Table 109. ALK-Abello Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. ALK-Abello Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. ALK-Abello Recent Developments
Table 112. Stallergenes Greer Company Information
Table 113. Stallergenes Greer Description and Major Businesses
Table 114. Stallergenes Greer Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Stallergenes Greer Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Stallergenes Greer Recent Developments
Table 117. Merck Company Information
Table 118. Merck Description and Major Businesses
Table 119. Merck Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Merck Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Merck Recent Developments
Table 122. Allergy Therapeutics Company Information
Table 123. Allergy Therapeutics Description and Major Businesses
Table 124. Allergy Therapeutics Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Allergy Therapeutics Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Allergy Therapeutics Recent Developments
Table 127. WOLW Pharma Company Information
Table 128. WOLW Pharma Description and Major Businesses
Table 129. WOLW Pharma Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. WOLW Pharma Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. WOLW Pharma Recent Developments
Table 132. HAL Company Information
Table 133. HAL Description and Major Businesses
Table 134. HAL Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. HAL Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. HAL Recent Developments
Table 137. Holister Stier Company Information
Table 138. Holister Stier Description and Major Businesses
Table 139. Holister Stier Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Holister Stier Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Holister Stier Recent Developments
Table 142. Leti Company Information
Table 143. Leti Description and Major Businesses
Table 144. Leti Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Leti Allergy Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Leti Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Allergy Vaccine Distributors List
Table 150. Allergy Vaccine Customers List
Table 151. Allergy Vaccine Market Trends
Table 152. Allergy Vaccine Market Drivers
Table 153. Allergy Vaccine Market Challenges
Table 154. Allergy Vaccine Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Allergy Vaccine Product Picture
Figure 2. Global Allergy Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Allergy Vaccine Market Share by Type in 2022 & 2029
Figure 4. Subcutaneous Immunotherapy Product Picture
Figure 5. Sublingual Immunotherapy Product Picture
Figure 6. Global Allergy Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Allergy Vaccine Market Share by Application in 2022 & 2029
Figure 8. Allergic Rhinitis
Figure 9. Allergic Asthma
Figure 10. Other
Figure 11. Allergy Vaccine Report Years Considered
Figure 12. Global Allergy Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Allergy Vaccine Revenue 2018-2029 (US$ Million)
Figure 14. Global Allergy Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Allergy Vaccine Revenue Market Share by Region (2018-2029)
Figure 16. Global Allergy Vaccine Sales 2018-2029 ((K Units)
Figure 17. Global Allergy Vaccine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Allergy Vaccine Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Allergy Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Allergy Vaccine Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Allergy Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Allergy Vaccine Sales YoY (2018-2029) & (K Units)
Figure 23. China Allergy Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Allergy Vaccine Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Allergy Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Allergy Vaccine Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Allergy Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Allergy Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Allergy Vaccine in the World: Market Share by Allergy Vaccine Revenue in 2022
Figure 30. Global Allergy Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Allergy Vaccine Sales Market Share by Type (2018-2029)
Figure 32. Global Allergy Vaccine Revenue Market Share by Type (2018-2029)
Figure 33. Global Allergy Vaccine Sales Market Share by Application (2018-2029)
Figure 34. Global Allergy Vaccine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Allergy Vaccine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Allergy Vaccine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Allergy Vaccine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Allergy Vaccine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Allergy Vaccine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Allergy Vaccine Sales Share by Country (2018-2029)
Figure 41. U.S. Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Allergy Vaccine Sales Market Share by Type (2018-2029)
Figure 44. Europe Allergy Vaccine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Allergy Vaccine Sales Market Share by Application (2018-2029)
Figure 46. Europe Allergy Vaccine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Allergy Vaccine Revenue Share by Country (2018-2029)
Figure 48. Europe Allergy Vaccine Sales Share by Country (2018-2029)
Figure 49. Germany Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. France Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. China Allergy Vaccine Sales Market Share by Type (2018-2029)
Figure 55. China Allergy Vaccine Revenue Market Share by Type (2018-2029)
Figure 56. China Allergy Vaccine Sales Market Share by Application (2018-2029)
Figure 57. China Allergy Vaccine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Allergy Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Asia Allergy Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Allergy Vaccine Sales Market Share by Application (2018-2029)
Figure 61. Asia Allergy Vaccine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Allergy Vaccine Revenue Share by Region (2018-2029)
Figure 63. Asia Allergy Vaccine Sales Share by Region (2018-2029)
Figure 64. Japan Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. India Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Allergy Vaccine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Allergy Vaccine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Allergy Vaccine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Allergy Vaccine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Allergy Vaccine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Allergy Vaccine Sales Share by Country (2018-2029)
Figure 75. Brazil Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Allergy Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. Allergy Vaccine Value Chain
Figure 81. Allergy Vaccine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries